RGEN - Repligen Corp Qarzning balans kapitallashuviga nisbati

Repligen Corp (RGEN) tovar belgisi

Repligen Corporation (RGEN) sarf materiallari va filtrlarga bo'lgan barqaror talabga asoslanib, yuqori darajadagi daromad bashoratini saqlab qolmoqda. Kompaniya hozirda gen terapiyasi uchun muhim tizimlarning yetkazib berishini kengaytirmoqda, bu esa uning operatsiyalarini barqarorlashtirmoqda. 0.35 darajasiga yetgan ushbu narxlar grafigi, hamkorlar uchun logistik ishonchlilikni kafolatlovchi Yevropa va AQShdagi steril ishlab chiqarish zavodlarining egaligiga tegishli ma'lumotlarni to'ldiradi.

Repligen Corporation (RGEN) - Balans qiymatiga qarzlar 04.07.2022dan 27.10.2026gacha

Repligen Corp (RGEN) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Repligen Corporation|RGEN - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Repligen Inc.|RGEN - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Repligen|RGEN - Kompaniyaning xususiy kapitali|Bozor qiymatining balans qiymatiga nisbati repligen.com|RGEN - Kompaniya aktivlarining umumiy qiymati
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Repligen Corporation|RGEN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Repligen Corp.|RGEN - Kompaniyaning umumiy qarz majburiyatlari|Balans kapitallashuviga qarzlar Repligen Inc.
Kompaniyaning fundamental tahlili:Repligen Corporation, RGEN
Repligen Corp original mahsuloti

Repligen Corporation (RGEN) uchun ushbu ko'rsatkich kapital tuzilmasidagi qarz mablag'larining ulushini aks ettiradi, bunda umumiy majburiyatlar va kitob kapitalizatsiyasi o'rtasidagi nisbat tahlili biznesning moliyaviy barqarorligini baholash imkonini beradi. Ushbu koeffitsiyentning pasayishi qarz yuklamasining optimallashtirilganini tasdiqlaydi, bu esa biotexnologiya startaplari uchun investitsiya budjetlarining qisqarishi va uskunalar talabining pasayishi sharoitida defolt risklarini minimallashtirish uchun juda muhimdir.

Repligen Corporation raqobatchilari

Balans kapitallashuviga qarzlar TEM (Tempus AI Inc)|qiagen.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Ionis (IONS)|RNA - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar CRSP|WGS (GeneDx Corp) - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Ultragenyx Pharmaceutical RARE|Qarzlarning balans kapitallashuviga nisbati BEAM|Qarzning balans kapitallashuviga nisbati Sarepta (SRPT)|Qarzning balans kapitallashuviga nisbati Twist Bioscience Inc (TWST)|Balans kapitallashuviga qarzlar TXG|Sof aktivlarga qarzlar Intellia Corp NTLA|Balans kapitallashuviga qarzlar STOK|BLFS - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar WVE|MAZE (Maze Therapeutics, Inc.) - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Sionna Pharma (SION)|Qarzning balans qiymatiga nisbati Prime Medicine Bio (PRME)|Taysha Gene Therapies (TSHA) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati uniqure.com (QURE)|MeiraGTx - Balans kapitallashuviga qarzlar|REGENXBIO Inc - Qarzning balans qiymatiga nisbati|SLDB (Solid Bio) - Qarzning balans kapitallashuviga nisbati|OCGN: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Pacific Biosciences PACB|BNTC (benitec.com) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Design Therapeutics, Inc. DSGN|Qarzlarning balans kapitallashuviga nisbati RCKT|4D Molecular Therapeutics Inc - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar LXEO (lexeotx.com)|Qarzning balans kapitallashuviga nisbati Korro Bio|Qarzning sof aktivlarga nisbati editasmedicine.com EDIT|Silence Therapeutics plc - Balans kapitallashuviga qarzlar|ProQR Therapeutics N.V. (PRQR) - Balans kapitallashuviga qarzlar|CDXS - Qarzning balans qiymatiga nisbati|Sangamo BioSciences (SGMO) - Qarzning balans kapitaliga nisbati|NAUT: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar MGX|Precision BioSciences, Inc. - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar GBIO (generationbio.com)|BOLD - Qarzning balans kapitallashuviga nisbati|Exicure Inc. - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati Celsion Corporation (IMNN)|PHIO - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar MBIO (mustangbio.com)|TransCode Therapeutics, Inc. (RNAZ) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar BNGO (Bionano Genomics Inc.)|Balans qiymatiga qarzlar APDN|Qarzning balans kapitallashuviga nisbati bluebird bio, Inc. BLUE|Qarzning balans qiymatiga nisbati immunoprecise.com (IPA)|OMGA - Balans kapitallashuviga qarzlar|Singular Genomics Systems, Inc. - Qarzning balans qiymatiga nisbati|Regulus Therapeutics Inc (RGLS) - Qarzning balans kapitallashuviga nisbati|SYRS - Qarzning balans qiymatiga nisbati|TBIO: Balans kapitallashuviga qarzlar|TCON (traconpharma.com) - Balans kapitallashuviga qarzlar|UBX - Qarzning balans kapitallashuviga nisbati